evidence answer

Is Vitamin K Bone Density Randomized Trial safe?

Updated August 2026

Quick Answer

Vitamin K Bone Density Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: No significant differences were found between groups in overall BMD or bone metabolic markers after six months.

Key Takeaways

  • 01No significant differences were found between groups in overall BMD or bone metabolic markers after six months. [Jung S (2026)]
  • 02Background/objectives Adequate calcium and vitamin D intake, along with regular physical activity, is essential for maintaining skeletal health in postmenopausal women. [Jung S (2026)]
  • 03In populations with low dairy consumption, sustainable and bioavailable calcium sources are required to support bone integrity. [Jung S (2026)]
  • 04MASLD and Bone Markers in Postmenopause: Highlighting the Critical Gap of Vitamin D Status and the Need for Targeted Supplementation Trials. [Wen X (2026)]
The current Migaku evidence database contains 2 reusable source documents for Vitamin K Bone Density Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - No significant differences were found between groups in overall BMD or bone metabolic markers after six months. [Jung S (2026); evidence level 2] - Background/objectives Adequate calcium and vitamin D intake, along with regular physical activity, is essential for maintaining skeletal health in postmenopausal women. [Jung S (2026); evidence level 2] - In populations with low dairy consumption, sustainable and bioavailable calcium sources are required to support bone integrity. [Jung S (2026); evidence level 2] - MASLD and Bone Markers in Postmenopause: Highlighting the Critical Gap of Vitamin D Status and the Need for Targeted Supplementation Trials. [Wen X (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Learn next

Keep learning from this answer

SupplementVitamin CA potent water-soluble antioxidant that protects cells, supports collagen synthesis, and boosts...SupplementVitamin K2A critical vitamin that directs calcium into the bones and teeth while preventing calcification...SupplementVitamin D3A fat-soluble vitamin crucial for calcium absorption, bone health, immune function, and mood reg...SupplementVitamin K2 (MK-7)The missing partner to vitamin D3 — directs calcium into bones and away from arteries.GuideVitamin K Bone Density Randomized Trial: What the Evidence SaysVitamin K Bone Density Randomized Trial has 2 source documents in the current Migaku evidence da...GuideVitamin K2 Bone Density Randomized Trial: What the Evidence SaysVitamin K2 Bone Density Randomized Trial has 2 source documents in the current Migaku evidence d...GuideMagnesium Bone Density Randomized Trial: What the Evidence SaysMagnesium Bone Density Randomized Trial has 2 source documents in the current Migaku evidence da...GuideVitamin K Bone Turnover Randomized Trial: What the Evidence SaysVitamin K Bone Turnover Randomized Trial has 2 source documents in the current Migaku evidence d...

Sources

  1. Effects of Eggshell Calcium- and Vitamin D-Fortified HMR Combined with Aerobic Exercise on Bone Mineral Density in Postmenopausal Women: A Pilot Randomized Controlled Trial.
  2. MASLD and Bone Markers in Postmenopause: Highlighting the Critical Gap of Vitamin D Status and the Need for Targeted Supplementation Trials.